Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Evaluation of viral mRNA modification

ABSTRACT: Evaluation of viral mRNA modification

PROVIDER: PRJNA699484 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13630783_1.fastq.gz	Fastqsanger.gz
	SRR13630783_2.fastq.gz	Fastqsanger.gz
	SRR13630784_1.fastq.gz	Fastqsanger.gz
	SRR13630784_2.fastq.gz	Fastqsanger.gz
	SRR13630785_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Evaluation of viral mRNA modification

Project description:We report viral mRNA modification in bat morbillivirus infection

2021-07-31 | GSE166158 | GEO

Evaluation of viral transcriptome

Project description:Evaluation of viral transcriptome

| PRJNA699536 | ENA

Pseudouridine modification detection in mRNA

Project description:Pseudouridine modification detection in mRNA

| PRJEB56934 | ENA

Influenza NS1 Drives N6-Methyladenosine (m6A)-Mediated Autoregulation of Viral mRNA Splicing

Project description:Influenza A virus replication requires precise balance between unspliced and spliced viral mRNAs. However, the regulatory mechanisms governing viral mRNA splicing remain poorly understood. In this study, we uncover an epigenetic strategy whereby the viral NS1 protein autoregulates its own mRNA splicing via N6-methyladenosine (m6A) modification. Specifically, m6A modification at residue A385 on NS mRNA recruits the m6A reader YTHDC1, which competitively inhibits the splicing factor SRSF3 from binding proximal sites. Importantly, we demonstrate that the A385 m6A site is conserved and essential for splicing regulation in the NS segment across human and avian influenza strains. Our findings suggest that, by dynamically modulating m6A levels, NS1 fine-tunes viral mRNA processing to enhance replication efficiency. This work elucidates NS1 as an m6A-driven splicing regulator and identifies this conserved m6A site as a potential target for broad-spectrum antiviral development.

2025-09-24 | GSE308596 | GEO

Viral and host M6A modification changes after infection of MARC145 cells by PRRSV SD16

Project description:Viral infections can influence the dynamic changes of the epitranscriptome. However, due to the lack of understanding regarding the impact of PRRSV (Porcine reproductive and respiratory syndrome virus) on m6A modifications in host cells in vitro, we investigated the changes in viral and host mRNA N6-methyladenosine (m6A) modifications during the infection of MARC145 cells by the PRRSV SD16 strain. We found that the expression of major epitranscriptomic proteins changed before and after viral infection, reprogramming both the viral and host epitranscriptomes. Specifically, the expression of METTL3 increased after PRRSV infection. Overexpression of METTL3 promoted PRRSV gene expression and replication, while knockdown of METTL3 suppressed PRRSV gene expression and replication. These findings reveal the dynamic characteristics of the mRNA m6A modification program during PRRSV replication in vitro.

2024-11-20 | GSE281664 | GEO

Coronavirus NSP14 Drives Internal m7G Modification to Rewire Host Splicing and Promote Viral Replication

Project description:SARS-CoV-2, the causative agent of COVID-19, manipulates host gene expression through multiple mechanisms, including disruption of RNA processing. Here, we identify a novel function of the viral nonstructural protein 14 (NSP14) in inducing N7-methylguanosine (m7G) modification in the internal sequences of host mRNA. We demonstrate that NSP14 catalyzes the conversion of guanosine triphosphate (GTP) to m7GTP, which is subsequently incorporated into mRNA by RNA polymerase II, resulting in widespread internal m7G modification. This activity is dependent on NSP14's N7-methyltransferase (N7-MTase) domain and is enhanced by interaction with NSP10. Internal m7G modification by NSP14 predominantly occurs in the nucleus and is conserved across alpha-, beta- and gamma-coronaviruses. Mechanistically, we show that this RNA modification disrupts normal splicing by promoting intron retention and generating novel splice junctions. Importantly, inhibition of m7G modification, through pharmacological targeting of NSP14 or RNA polymerase II, impairs SARS-CoV-2 replication, indicating that the virus hijacks host transcriptomic machinery to support infection. Our findings reveal a previously unrecognized epitranscriptomic mechanism by which coronaviruses reprogram host gene expression and suggest that NSP14-induced m7G modification is a potential therapeutic target.

2025-09-05 | GSE307386 | GEO

IGF2BP3 promotes mRNA degradation through internal m7G modification

Project description:IGF2BP3 promotes mRNA degradation through internal m7G modification

| PRJNA1006739 | ENA

Evaluating levels of Vaccinia viral mRNA translation

Project description:Evaluating levels of Vaccinia viral mRNA translation

| PRJNA952251 | ENA

Evaluation of mRNA expression in the equine chorioallantoic membrane

Project description:Evaluation of mRNA expression in the equine chorioallantoic membrane

| PRJNA423054 | ENA

Evaluating levels of Vaccinia viral mRNA translation

Project description:We have sequenced polysome enriched mRNA to determine levels of viral transcript translation.